印度进步超核:过去,现在和未来
Srinivas Raju1, Kuldeep Shetty2, Lulup Sahoo3
1Department of Neurology, Manipal Hospital, Hebbal, Bengaluru, Karnataka, India.
Annals of Indian Academy of Neurology
|December 2, 2024
概括
印度关于渐进性超核麻 (PSP) 的研究已经从单一中心研究演变为合作,泛印度项目. 未来的研究应该集中在遗传学,风险因素和这种神经退行性疾病的治疗方法上.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医学研究 医学研究
背景情况:
- 渐进性超核麻 (PSP) 是一种重要的神经退行性疾病,在全球范围内,特别是印度,研究兴趣越来越大.
- 几十年的印度研究为了解PSP做出了贡献,自1974年以来有80多篇出版物.
研究的目的:
- 审查在印度进行的进步超核麻 (PSP) 研究的景观.
- 分析历史研究趋势,并突出当前的举措和未来的方向,PSP管理在该地区.
主要方法:
- 从1974年到2023年,对PSP的印度研究出版物的综合审查.
- 分析研究主题,方法,表型 (主要是PSP-Richardson综合征) 和患者人口统计数据.
- 确定向协作,多中心研究模式的转变,以PAn印度注册PSP (PAIR-PSP) 项目为例.
主要成果:
- 历史研究主要涉及单一中心研究,招募人数各不相同.
- PSP-Richardson综合征是观察到的最常见的表型,患者通常在64岁左右被诊断出来.
- 最近的一种趋势表明,正朝着大规模,多中心和全印度合作项目迈进.
结论:
- 印度对PSP的研究已经从孤立的努力转变为协调,全国性的举措.
- 需要进一步研究遗传因素,识别风险,以及开发有效的PSP治疗和预防策略.
- 印度庞大的人口使其能够为了解PSP和其他病症做出关键贡献.
相关概念视频
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K


